Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA

Intubation Complication Clinical Trial

Official title:

Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02969889
• Other study ID #: KOU KAEK 2014/137
• Status: Completed
• Phase: N/A
• First received: November 18, 2016
• Last updated: February 2, 2017
• Start date: June 2016
• Est. completion date: November 2016

Study information

• Verified date: February 2017
• Source: Kocaeli University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

bmı > 35 morbidly obese patients requiring endotracheal intubation enrolled in this trial. Divided into two groups Airtraq and ILMA. their effectiveness is evaluated.

Description:

80 patients, 18-65 years of aged ASA I-III, BMI> 35 patients enrolled in this trial.

Divided into two groups ; Airtraq and ILMA .

BMI>35, upper airway tumour , respiratory infection less than ten days, excluded from this study.

patients demographic and airway variables were recoded. Patients were premedicated. After standard anesthesia induction, anesthesia was induced with propofol and fentanyl. Rocuronium was used for neuromuscular blockade.

The device insertion and intubation times, number of intubation attempts, mucosal damage, need for optimization maneuvers, effects on hemodynamic parameters and postoperative minor complications were recorded.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: November 2016
• Est. primary completion date: November 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:18-65 years of age

• ASA I-III

• BMI>35

Exclusion Criteria:BMI<35

• patients have airway tumor

• patients undergoing head and neck surgery

• upper respiratory infection less than 10 days prior the surgery

Related Conditions & MeSH terms

• Intubation Complication
• Intubation; Difficult or Failed

Intervention

Device:
• Airtraq
video laryngoscope with a channel
• ILMA

Locations

Country	Name	City	State
Turkey	Kocaeli University School of Medicine	Kocaeli

Sponsors (1)

Lead Sponsor	Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	intubation time	handling of the device till the endotracheal tube entering the glottis	1 minute